ADYX — Adynxx Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $8.41m
- $2.22m
Brief: Alliqua Biomedical reports Q1 loss per share of $0.28
Brief: Alliqua Biomedical reports Q3 non-GAAP loss per share $0.18
Brief: Alliqua Biomedical reports Q2 non-GAAP loss per share $0.20
Brief: Alliqua Biomedical, subsidiaries and Perceptive Credit Opportunities Fund entered into credit agreement
Brief: Alliqua Biomedical Q1 loss per share $0.48
Brief: Press release - Alliqua Biomedical announces expansion to licensing agreement with Celgene Corp's subsidiary
Brief: Alliqua Biomedical prices offering of 6.6 mln shares at $4.55 per share
Brief: Alliqua Biomedical Q1 revenue $2.1 million
Brief: Alliqua Biomedical receives coverage from medicare administrative contractor for Biovance
Brief: Alliqua Biomedical announces CEO David Johnson's 2014 compensation
Brief: Alliqua Biomedical Sees FY 2015 revenue $15.5-$18 mln
Brief: Alliqua says must pay $3 mln termination fee if agreement with Celleration ends
Brief: Alliqua Biomedical to buy Celleration
Brief: Alliqua Biomedical announces purchasing agreement with Premier
Brief: Alliqua Biomedical's Biovance assigned level II HCPCS Q code